Cite

HARVARD Citation

    Reuss, J. et al. (2020). Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer. Journal for immunotherapy of cancer. 8 (2), p. . [Online]. 
  
Back to record